Cancer & Disease Research Sponsored by Beckman Coulter
Liquid Biopsies Offer a Viable Alternative to Tissue Biopsies
Liquid biopsies are a set of minimally invasive diagnostic methods that analyze tumor-derived materials that can be found circulating in biological fluids, to provide information for the diagnosis, treatment, and monitoring of cancer. While tissue biopsies and imaging techniques remain the current standards of care in the diagnosis of solid tumors, they have risks and limitations and limitations, some of which can be overcome by the use of liquid biopsy in clinical oncology, as an alternative or complementary technique to the current standards of care.  Discuss
Experimental Therapeutic Treatment for Deadly Tick-Borne Virus
Findings of the treatment of Bourbon disease in mice were published on June 13 in PLOS Pathogens. Only a few cases of the newly discovered Bourbon virus have been reported, and two of them ended in death, partly because no specific treatments are available for the tick-borne illness. Now, researchers at Washington University School of Medicine in St. Louis have identified an experimental antiviral drug, often used to treat the flu, that cures mice infected with the potentially lethal virus.  Discuss
Global Collaboration Launched for Large-Scale DNA Study Exploring Connection Between Genetics and Disease
A new partnership was announced between Intermountain Healthcare and deCODE Genetics to collaborate on the largest DNA mapping effort undertaken in the US from a single population. The initiative, called the HerediGene: Population Study, will analyze the complete DNA of 500,000 participants.  Discuss
Evolution of the Pap Smear
This May we recognized Georgios Papanikolaou for his revolutionary research in cervical cancer screening and prevention — you might even recall seeing him on the Google doodle on May 13th!  Discuss
UK Scientists Weigh In on Brexit and Laboratory Spending - Science Advisory Board Insights
The long road to a resolution of the Brexit situation appeared to be nearing an end earlier this year, with the deadline set for March 29 to finalize how Britain would exit the EU. A “hard” Brexit, the case if no EU-Britain agreement is reached, would remove Britain from the EU’s single market among other consequences. A “soft” exit would result in Britain remaining part of the single market, but not an EU member. With a government stalemate in Britain, the EU agreed to extend the deadline until October 31, though a deal may come sooner.  Discuss
The Promise of Targeted Therapeutics in Cancer Treatment
In 2018, the International Agency for Research on Cancer reported more than 18 million people were diagnosed with cancer. Between 40 and 45 million people worldwide are living with cancer and nearly 9.6 million people die. Cancer deaths occur in about 50% of people who develop cancer in developed countries; this is in contrast to 80% death rate in cancer patients in underdeveloped countries. The numbers are staggering. But there is hope, as scientists around the globe work on developing new technologies, in the form of targeted therapies, to combat the incidence of cancer.  Discuss
The Intersection of Life Scientists and Social Media: A Revolution
How do your peers receive information online and how do they utilize social media as a means of learning new information and sharing content? These are just a few of the questions that our colleagues at BioInformatics Inc. explored in a recent report about digital marketing to life scientists.  Discuss
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter